Showing results (21-30 of 295) with videos related to

Sort By:
Pageof 30
Neuroscience|July 30, 1999
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsyG Bregola, K Varani, S Gessi, et al.
Arzneimittel-Forschung|June 1, 1986
Crystallographic and conformational studies on histamine H1-receptor antagonists. IV. On the stereochemical vector of antihistaminic activityP A Borea, V Bertolasi, G Gilli
European Journal of Pharmacology|February 9, 1988
Temperature dependence of the binding of mu, delta and kappa agonists to the opiate receptors in guinea-pig brainP A Borea, G M Bertelli, G Gilli
The Journal of Pharmacy and Pharmacology|June 1, 1990
Normal phase HPLC as a model system of specific benzodiazepine-receptor bindingG Gilli, M C Pietrogrande, P A Borea
British Journal of Pharmacology|August 28, 2001
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cellsS Gessi, K Varani, S Merighi, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 30, 1999
Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studiesK Varani, A Rizzi, G Calo, et al.
Cellular and Molecular Life Sciences : CMLS|September 7, 2005
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptorsK Varani, F Portaluppi, S Gessi, et al.
Molecular Pharmacology|April 1, 1987
Stereochemical features controlling binding and intrinsic activity properties of benzodiazepine-receptor ligandsP A Borea, G Gilli, V Bertolasi, et al.
Arzneimittel-Forschung|January 1, 1980
Quantitative structure-activity relationship in 1-substituted ureidophenoxy-3-amino-2-propanols, a class of beta-adrenergic blocking agentsP A Borea, A Bonora, V Bertolasi, et al.
European Journal of Pharmacology|February 26, 1991
The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brainM Trampus, E Ongini, K Varani, et al.
Pageof 30